Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,382 | 10,476 | 33,413 | -119,337 | -99,404 |
| Depreciation Amortization | 491 | 346 | 130 | 396 | 279 |
| Accounts receivable | -7,264 | -8,517 | -5,997 | N/A | 0 |
| Accounts payable and accrued liabilities | 1,652 | -2,569 | -2,829 | 852 | 1,800 |
| Other Working Capital | -3,969 | -9,467 | -8,527 | 3,444 | 9,145 |
| Other Operating Activity | -41,221 | -40,886 | -48,051 | 23,414 | 14,644 |
| Operating Cash Flow | $-68,693 | $-50,617 | $-31,861 | $-91,231 | $-73,536 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -512 | -441 | -400 | -175 | -131 |
| Other Investing Activity | 62,010 | 62,010 | 62,010 | -2,610 | -2,610 |
| Investing Cash Flow | $61,498 | $61,569 | $61,610 | $-2,785 | $-2,741 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 108,214 | 107,966 | 107,835 | 2,004 | 585 |
| Financing Cash Flow | $108,214 | $107,966 | $107,835 | $2,004 | $585 |
| Exchange Rate Effect | 77 | 35 | 53 | -490 | -177 |
| Beginning Cash Position | 114,634 | 114,634 | 114,634 | 207,136 | 207,136 |
| End Cash Position | 215,730 | 233,587 | 252,271 | 114,634 | 131,267 |
| Net Cash Flow | $101,096 | $118,953 | $137,637 | $-92,502 | $-75,869 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,693 | -50,617 | -31,861 | -91,231 | -73,536 |
| Capital Expenditure | -512 | -441 | -400 | -175 | -131 |
| Free Cash Flow | -69,205 | -51,058 | -32,261 | -91,406 | -73,667 |